跳至主要内容
临床试验/CTRI/2024/05/067407
CTRI/2024/05/067407招募中3 期

The efficacy of Mustadikwathghanavati in the management of Prameha - NI

Dr Archana Daundkar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 30 to 60 years
  • Newly diagnosed Patients having signs and symptoms of Prameha w.s.r to Type 2 Diabetes Mellitus
  • Patients having F BSL-126 to 164 mg/dl PPBSL-140 to180 mg/dl and HbA1c 6.5% to 8%
  • BMI in between 23-45 kg/m2
  • Patients having stable dose of metformin for whole trial period.

排除标准

  • Known patient of Type 1 DM
  • Patients on insulin or oral steroid treatment.
  • Patients with other known systemic disorders
  • Patient with known micro /macrovascular complications related to Diabetes such as CKD, Renal parenchymal Disease, Hepatic Dysfunction.
  • Pregnant women and lactating Mothers.
  • Patients unable to provide written informed consent.

研究者

发起方
Dr Archana Daundkar

相似试验